Downregulation of amyloid precursor protein (APP) expression following post-traumatic cyclosporin-A administration

Journal of Neurotrauma

Volumn 21, Issue 11, 2004, Pages 1562-1572

  Van Den Heuvel, Corinna ^a   Donkin, James J ^a   Finnie, John W ^b,c   Blumbergs, Peter C ^a,b   Kuchel, Tim ^c   Koszyca, Barbara ^a   Manavis, Jim ^b   Jones, Nigel R ^a   Reilly, Peter L ^a   Vink, Robert ^a,b  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b HANSON INSTITUTE   (Australia)

^c INSTITUTE OF MEDICAL AND VETERINARY SCIENCE   (Australia)

Author keywords

Amyloid precursor protein; Cyclosporin A; Head injury model; Immunocytochemistry; RT PCR; Sheep; Traumatic brain injury

Indexed keywords

AMYLOID PRECURSOR PROTEIN; CYCLOSPORIN A; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; BRAIN INJURY; CONTROLLED STUDY; DRUG EFFECT; GENE EXPRESSION REGULATION; GRAY MATTER; HEAD INJURY; IMMUNOCYTOCHEMISTRY; NONHUMAN; PROTEIN EXPRESSION; RNA SYNTHESIS; SHEEP;

EID: 8744242071     PISSN: 08977151     EISSN: None     Source Type: Journal    
DOI: 10.1089/0897715042441783     Document Type: Article

References (54)

1. BRAMLETT, H.M., KRAYDIEH, S., GREEN, E.J., et al. (1997). Temporal and regional patterns of axonal damage following traumatic brain injury: a beta-amyloid precursor protein immunocytochemical study in rats. J. Neuropathol. Exp. Neurol. 56, 1132-1141.
2. BUKI, A., OKONKWO, D.O., and POVLISHOCK, J.T. (1999). Postinjury cyclosporin A administration limits axonal damage and disconnection in traumatic brain injury. J. Neurotrauma 16, 511-521.
3. CAPUTI, A., BARINDELLI, S., PASTORINO, L., et al. (1997). Increased secretion of the amino-terminal fragment of amyloid precursor protein in brains of rats with a constitutive up-regulation of protein kinase C. J. Neurochem. 68, 2523-2529.
4. CLARRIS, H.J., KEY, B., SMALL, D., et al. (1994). Secretion of nerve growth factor from septum stimulates outgrowths and release of the amyloid protein precursor of Alzheimer's disease. J. Neurosci. Res. 38, 248-258.
5. DE STROOPER, B., SAFTIG, P., CRAESSAERTS, K., et al. (1998). Deficiency of presenilin-I inhibits the normal cleavage of amyloid precursor protein. Nature 391, 387-390.
6. DOYLE, E., BRUCE, M.T., BREEN, K.C., S et al. (1990). Intraventricular infusions of antibodies to amyloid (beta)-protein precursor impair the acquisition of a passive avoidance response in the rat. Neurosci. Lett. 115, 97-102.
7. FURUKAWA, K., SOPHER, B.L., RYDEL, R.E., et al. (1996a). Increased activity-regulating and neuroprotective efficacy of alpha-secretase-derived secreted amyloid precursor protein conferred by a C-terminal heparin-binding domain. J. Neurochem. 67, 1882-1896.
8. + channels and suppression of neuronal activity by secreted beta-amyloid-precursor protein. Nature 379, 74-78.
9. GAMES, D., ADAMS, D., ALESSANDRINI, R., et al. (1995). Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein. nature. 373, 523-527.
10. GITTER, B.D., WATERS, D.C., THRELKELD, P.G., et al. (1995) Cyclosporin A is a substance P (tachykinin NK1) receptor antagonist. Eur. J. Pharmacol. 289, 439-446.
11. GOODMAN, Y., and MATTSON, M.P. (1994). Secreted forms of beta-amyloid precursor protein protect hippocampal neurons against amyloid beta-peptide-induced oxidative injury. Exp. Neurol. 128, 1-12.
12. HEATH, D. L., and VINK, R. (1999). Optimization of magnesium therapy after severe diffuse axonal brain injury in rats. J. Pharmacol. Exp. Ther. 288, 1311-1316.
13. HELEKAR, S.A., and PATRICK, J. (1997). Peptidyl prolyl cis-trans isomerase activity of cyclophilin A in functional homooligomeric receptor expression. Proc. Natl. Acad. Sci. USA 94, 5432-5437.
14. HUBER, G., MARTIN, J.R., LOFFLER, J., et al. (1993). Involvement of amyloid precursor protein in memory formation in the rat: an indirect antibody approach. Brain Res. 603, 348-352.
15. ISHIDA, A., FURUKAWA, K., KELLER, J.N., et al. (1997). Secreted form of (beta)-amyloid precursor protein shifts the frequency dependence for induction of LTD, and enhances LTP in hippocampal slices. Neuroreport 8, 2133-2137.
16. JIN, L., NINOMIYA, H., ROCH, J., et al. (1994). Peptides containing the RERMS sequence of amyloid (Beta)/A4 protein precursor bind cell surface and promote neurite extension. J. Neurosci. 14, 5461-5470.
17. 42 deposition in a transgenic mouse model of Alzheimer disease. Proc. Natl. Acad. Sci. USA. 94, 1550-1555.
18. KANG, J., LEMAIRE, H.G., UNTERBECK, A., et al. (1987). The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature 325, 733-736.
19. KOO, E.H., and SQUAZZO, S.L. (1994). Evidence that production and release of amyloid beta-protein involves the endocytic pathway. J. Biol. Chem. 269, 17386-17389.
20. KRISTIAN, T., and SIESJO, B.K. (1998). Calcium in ischaemic cell death. Stroke 29, 705-718.
21. LEE, J., and WURTMAN, R.J. (2000). Regulation of APP synthesis and secretion by neuroimmunophilin ligands and cyclooxygenase inhibitors. Ann. NY Acad. Sci. 920, 261-268.
22. LEWEN, A., LI, G.L., NILSSON, P., OLSSON, Y., et al. (1995). Traumatic brain injury in rat produces changes in β-amyloid precursor protein immunoreactivity. NeuroReport 6, 357-360.
23. LEWEN, A., LI, G.L., OLSSON, Y., and HILLERED, L. (1996). Changes in microtubule-associated protein 2 and amyloid precursor protein immunoreactivity following traumatic brain injury in rat: influence of MK-801 treatment. Brain Res. 719, 161-171.
24. LEWIS, S. B., FINNIE, J. W., BLUMBERGS, P. C., et al. (1996) A head impact model of early axonal injury in the sheep. J. Neurotrauma. 13, 505-514.
25. MATTSON, M.P., CHENG, B., CULWELL, A.R., et al. (1993). Evidence for excitoprotective and intraneuronal calcium-regulating roles for secreted forms of the beta-amyloid precursor protein. Neuron 10, 243-254.
26. MATTSON, M.P., GUO, Z.H., and GEIGER, J.D. (1999). Secreted form of amyloid precursor protein enhances basal glucose and glutamate transport and protects against oxidative impairment of glucose and glutamate transport in synaptosomes by a cyclic-GMP-mediated mechanism. J. Neurosci. 73, 532-537.
27. MILWARD, E.A., PAPADOPOULOS, R., FULLER, S.J., et al. (1992). The amyloid protein precursor of Alzheimer's disease is a mediator of the effects of nerve growth factor on neurite outgrowth. Neuron 9, 129-137.
28. MOYA, K.L., BENOWITZ, L.I., SCHNEIDER, G.E., et al. (1994). The amyloid precursor protein is developmentally regulated and correlated with synatogenesis. Dev. Biol. 161, 597-603.
29. MUCKE, L., MASLIAH, E., JOHNSON, W.B., et al. (1994). Synaptotrophic effects of human amyloid (beta) protein precursor in the cortex of transgenic mice. Brain Res. 666, 151-167.
30. OHSAWA, I., HIROSE, Y., ISHIGURO, M., et al. (1995). Expression, purification, and neurotrophic activity of amyloid precursor protein-secreted forms produced by yeast. Biochem. Biophys. Res. Commun. 213, 52-58.
31. OKONKWO, D.O., BUKI, A., SIMAN, R., et al. (1999). Cyclosporin A limits calcium-induced axonal damage following traumatic brain injury. Neuroreport 10, 1-6.
32. OKONKWO, D.O., and POVLISHOCK, J.T. (1999). A single intrathecal bolus of cyclosporin before injury preserves mitochondrial integrity and attenuates axonal disruption following traumatic brain injury. J. Cereb. Blood Flow Metab. 19, 443-451.
33. PARKS, J.K., SMITH, T.S., TRIMMER, P.A., et al. (2001). Neurotoxic Ab peptides increase oxidative stress in vivo through NMDA-receptor and nitric-oxide-synthase mechanisms, and inhibit complex IV activity and induce a mitochondrial permeability transition in vitro. J. Neurochem. 76, 1050-1056.
34. PIERCE, J.E., TROJANOWSKI, J.Q., GRAHAM, D.I., et al. (1996). Immunohistochemical characterization of alterations in the distribution of amyloid precursor proteins and beta-amyloid peptide after experimental brain injury in the rat. J. Neurosci. 16, 1083-1090.
35. PYRZYNSKA, B., LIS, A., MOSIENIAK, G., et al. (2001). Cyclosporin A - sensitive signaling pathway involving calcineurin regulates survival of reactive astrocytes. Neurochem. Int. 38, 409-415.
36. REISS, P., BRAREYRE, F.M., SAATMAN, K.E., et al. (2001). Effects of chronic, post-injury Cyclosporin A administration on motor and sensorimotor function following severe, experimental traumatic brain injury. Restor. Neurol. Neurosci. 18, 1-8.
37. ROCH, J., MASLIAH, E., ROCH-LEVECQ, A., et al. (1994). Increase of synaptic density and memory retention by a peptide representing the trophic domain of the amyloid (beta)/A4 protein precursor. Proc. Natl. Acad. Sci. USA 91, 7450-7454.
38. SALBAUM, J.M., WEIDEMANN, A., LEMAIRE, H.G., et al. (1988). The promoter of Alzheimer's disease amyloid A4 precursor gene. Embo J. 7, 2807-2813.
39. SCHEFF, S. W., and SULLIVAN, P. G. (1999). Cyclosporin A significantly ameliorates cortical damage following experimental traumatic brain injury in rodents. J. Neurotrauma 16, 783-792.
40. SELKOE, D.J. (1999). Translating cell biology into therapeutic advances in Alzheimer's disease. Nature 399, A23-A31.
41. SEO, J.H., KIM, S.H., KIM, H.S., et al. (2001). Effects of nicotine on APP secretion and Ab or CT105 induced toxicity. Biol. Psych. 49, 240-247.
42. SLACK, B.E., NITSCH, R.M., LIVNEH, E., et al. (1993). Regulation of amyloid precursor protein release by protein kinase C in Swiss 3T3 fibroblasts. Ann. NY Acad. Sci. 695, 128-131.
43. SMITH, D.H., NAKAMURA, M., McINTOSH, T.K., et al. (1998). Brain trauma induces massive hippocampal neuron death linked to a surge in β-amyloid levels in mice overexpressing mutant amyloid precursor protein. Am. J. Pathol. 153, 1005-1010.
44. SMITH-SWINTOSKY, V.L., PETTIGREW, L.C., CRADDOCK, S.D., et al. (1994). Secreted forms of β-amyloid precursor protein protect against ischemic brain injury. J. Neurochem. 63, 781-784.
45. STONE, J.R., SINGLETON, R.H., and POVLISHOCK, J.T. (2000). Antibodies to the C-terminus of the β-amyloid precursor protein (APP): a site specific marker for the detection of traumatic axonal injury. Brain Res. 871, 288-302.
46. SUEHIRO, E., and POVLISHOCK, J. T. (2001). Exacerbation of traumatically induced axonal injury by rapid posthypothermic rewarming and attenuation of axonal change by cyclosporin A. J. Neurosurg. 94, 493-498.
47. TAKAHASHI, T., and KAMIMURA, A. (2001). Cyclosporin A promotes hair epithelial cell proliferation and modulates protein kinase c expression and translocation in hair epithelial cells. J. Invest. Dermatol. 117, 605-611.
48. TREJO, J., MASSAMIRI, T., DENG, T., et al. (1994). A direct role for protein kinase C and the transcription factor Jun/AP-1 in the regulation of the Alzheimer's β-amyloid precursor protein gene. J. Biol. Chem. 269, 21682-21690.
49. VAN DEN HEUVEL, C., BLUMBERGS, P.C., FINNIE, J.W., et al. (1999). Upregulation of amyloid precursor protein messenger RNA in response to traumatic brain injury: an ovine head impact model. Exp. Neurol. 159, 441-450.
50. 4) therapy in traumatic brain injury. J. Neurotrauma 17, 1041-1053.
51. VAN DEN HEUVEL, C., BLUMBERGS, P., FINNIE, J., et al. (2000b). Upregulation of amyloid precursor protein and its mRNA in an experimental model of paediatric head injury. J. Clin. Neurosci. 7, 140-145.
52. WOLF, B.A., WERTKIN, A.M., JOLLY, Y.C., et al. (1995). Muscarinic regulation of Alzheimer's disease amyloid precursor protein secretion and amyloid β-protein production in human neuronal NT2N cells. J. Biol. Chem. 270, 4916-4922.
53. WOLFE, M.S., XIA, W., MOORE, C.L., et al. (1999). Peptidomimetric probes and molecular modeling suggest that Alzheimer's γ secretase is an intramembranous-cleaving aspartyl protease. Biochemistry 38, 4720-4727.
54. ZORATTI, M., and SZABO, I. (1995). The mitochondrial permeability transition. Biochim. Biophys. Acta 1241, 139-176.